Breaking News Instant updates and real-time market news.

HON

Honeywell

$153.70

-2.98 (-1.90%)

, CCJ

Cameco

$11.59

-0.11 (-0.94%)

07:30
10/12/18
10/12
07:30
10/12/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Thursday in Honeywell (HON), Cameco (CCJ), Ascena Retail (ASNA), American Eagle (AEO), Dean Foods (DF), Textron (TXT), and Sleep Number (SNBR).

HON

Honeywell

$153.70

-2.98 (-1.90%)

CCJ

Cameco

$11.59

-0.11 (-0.94%)

ASNA

Ascena Retail

$4.59

0.33 (7.75%)

AEO

American Eagle

$20.77

-0.3225 (-1.53%)

DF

Dean Foods

$7.17

-0.21 (-2.85%)

TXT

Textron

$65.09

-2.295 (-3.41%)

SNBR

Sleep Number

$31.60

-1.33 (-4.04%)

  • 16

    Oct

  • 18

    Oct

  • 19

    Oct

  • 24

    Oct

HON Honeywell
$153.70

-2.98 (-1.90%)

10/02/18
HSBC
10/02/18
DOWNGRADE
HSBC
Hold
Honeywell downgraded to Hold from Buy at HSBC
10/01/18
RBCM
10/01/18
INITIATION
Target $14
RBCM
Underperform
Garrett Motion initiated with an Underperform at RBC Capital
RBC Capital analyst Joseph Spak initiated Garrett Motion (GTX) with an Underperform rating and a price target of $14. The analyst says that while this pure-play company looks to "benefit from increased gasoline turbocharger penetration" after getting spun off from Honeywell (HON), he sees operational margin pressure from its diesel/gas mix shift. Spak adds that Garrett Motion is "positioned poorly" amid the long-term shift to battery electric vehicle technology, while also citing its high leverage and free cash flow pressure from its required asbestos liability payments to Honeywell.
09/26/18
OPCO
09/26/18
NO CHANGE
Target $184
OPCO
Outperform
Honeywell price target raised to $184 from $172 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Honeywell to $184 from $172 and adjusted 2019E EPS for best estimate without the pending spinoffs of Garrett and Resideo. The analyst continues to view ongoing Honeywell as a premium asset, with excellent proven financial controls and planning. He reiterates an Outperform rating on the shares.
09/17/18
BARD
09/17/18
NO CHANGE
Target $187
BARD
Outperform
Honeywell's flexible balance sheet overlooked, says Baird
Baird analyst Peter Arment met with Honeywell management and came away reiterating the company is well positioned for sustained healthy organic growth, continued margin expansion, and robust free cash flow that will bolster its already stellar balance sheet. The analyst said the company's fortress is its balance sheet, which is being overlooked by investors but can provide flexibility for M&A and protection from the next downturn. Arment reiterated his Outperform rating and $187 price target on Honeywell shares.
CCJ Cameco
$11.59

-0.11 (-0.94%)

09/28/18
SCOT
09/28/18
UPGRADE
SCOT
Sector Perform
Cameco upgraded to Sector Perform from Underperform at Scotiabank
Scotiabank analyst Orest Wowkodaw upgraded Cameco to Sector Perform from Underperform stating that the Tax Court of Canada ruling was "very favorable," appears to effectively end the company's long-standing tax dispute and represents the best possible outcome for the company. He increased his multiples to reflect the removal of the significant CRA overhang and raised his price target on Cameco shares to C$15 from C$12.
09/27/18
09/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Jernigan Capital (JCAP) upgraded to Buy from Hold at Jefferies with analyst George Hoglund saying he has an increasing near-term opportunity to acquire as many as 20 recently completed self-storage facilities in lease-up over the next 12-18 months. 2. Alaska Air (ALK) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying the shares warrant a premium valuation due to the likelihood of industry-leading unit revenue growth in fiscal 2019. 3. Cameco (CCJ) upgraded to Outperform from Market Perform at Raymond James with analyst Alexander Pearce citing the latest decision by the Tax Court of Canada in favor of the company in regards to its dispute of the reassessments ordered by Canada Revenue Agency. 4. CarMax (KMX) upgraded to Outperform from Neutral at Baird. 5. KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/18
BMOC
09/27/18
UPGRADE
Target $16
BMOC
Outperform
Cameco upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Alexander Pearce upgraded Cameco to Outperform from Market Perform and raised his price target to $16 from $14. The analyst cites the latest decision by the Tax Court of Canada in favor of the company in regards to its dispute of the reassessments ordered by Canada Revenue Agency, or CRA. Pearce contends that the decision, which had been a "significant overhang on the stock", could be worth as much as CAD 5 per share to its valuation, given that the company previously estimated related penalties of as much as CAD 2.15B.
09/28/18
09/28/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lowe's (LOW) upgraded to Buy from Hold at SunTrust with analyst Keith Hughes citing the company's latest Q2 earnings and the analyst meeting with its management suggesting an "internally focused" turnaround progressing at a "consistent pace" over the next 2-3 years. 2. Devon Energy (DVN) upgraded to Overweight from Neutral at Piper Jaffray with analyst Ryan Todd saying he sees a "high-quality onshore portfolio driving upper-quartile debt-adjusted cash flow growth and active disposal program as offering support for free cash flow momentum into 2019" and beyond. 3. HCP (HCP) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Joseph France saying after years of restructuring and strengthening its financials, HCP is now well positioned in each of its major businesses, particularly life science and medical office. 4. SAIC (SAIC) upgraded to Buy from Hold at Drexel Hamilton. 5. Cameco (CCJ) upgraded to Sector Perform from Underperform at Scotiabank with analyst Orest Wowkodaw saying the Tax Court of Canada ruling was "very favorable," appears to effectively end the company's long-standing tax dispute and represents the best possible outcome for the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ASNA Ascena Retail
$4.59

0.33 (7.75%)

06/05/18
RILY
06/05/18
NO CHANGE
Target $3.5
RILY
Neutral
Ascena Retail price target raised to $3.50 from $2.50 at B. Riley FBR
B. Riley FBR analyst Susan Anderson raised her price target for Ascena Retail Group to $3.50 saying same-store-sales improvement drove earnings to the high end of guidance in Q3. The analyst keeps a Neutral rating on the shares.
AEO American Eagle
$20.77

-0.3225 (-1.53%)

08/30/18
JEFF
08/30/18
NO CHANGE
Target $31
JEFF
Buy
American Eagle should be bought, especially on pullback, says Jefferies
Jefferies analyst Janine Stichter says that while American Eagle's Q2 results were "strong," with comp and margin upside, the company's guidance and elevated spending may give investors pause in the near term. The analyst, however, recommends buying the shares, especially given the pullback. She expects American Eagle's "strong" fundamentals to continue and that its and current investments in marketing/payroll to yield long-term benefits. Stichter lowered her price target for the shares to $31 from $33 and reiterates a Buy rating on the shares.
08/27/18
08/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. U.S. Steel (X) double downgraded to Underweight from Overweight at Morgan Stanley with analyst Piyush Sood saying steel prices are falling and he believes the recent price peak is "firmly behind" the market. Sood lowered his price target on U.S. Steel shares to $30 from $44. 2. Chipotle (CMG) downgraded to Underperform from Neutral at Wedbush with analyst Nick Setyan saying he sees increased risk to Chipotle's near-term same-store-sales growth and margin expectations, and continues to see risk to margin expectations through 2020. Setyan lowered his price target for the shares to $445 from $450. 3. American Eagle (AEO) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding citing valuation. 4. Oasis Midstream Partners (OMP) downgraded to Neutral from Overweight at JPMorgan with analyst Jeremy Tonet citing valuation. 5. Hibbett Sports (HIBB) downgraded to Hold from Buy at Canaccord with analyst Camilo Lyon saying he sees higher expense growth and "lackluster" comps dampening the company's growth prospects following Friday's Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/18
UBSW
08/30/18
NO CHANGE
Target $34
UBSW
Buy
American Eagle weakness a buying opportunity, says UBS
UBS analyst Jay Sole said to buy the dip in American Eagle following its Q2 results. The analyst raised his estimates and price target as he believes gross margins are likely to trend higher over time, the Aerie brand is on track to become a $2B brand, and the American Eagle brand is performing better than expected. Sole reiterated his Buy rating and raised his price target to $34 from $33 on American Eagle.
08/27/18
08/27/18
DOWNGRADE
Target $29

Neutral
American Eagle downgraded to Neutral on valuation at Wedbush
As previously reported, Wedbush analyst Jen Redding downgraded American Eagle (AEO) to Neutral from Outperform, with a $29 price target, on valuation. The analyst remains bullish on American Eagle over the long-term and maintains her beliefs that it is competitively positioned into BTS and the Holiday season. A strong denim season ahead also makes the story a favorite into BTS, she contends, adding that she sees improvement in core categories including apparel and accessories, and inventory management as key catalysts. Further, Redding notes that recent issues that plagued Victoria's Secret (LB) PINK through Q2 may provide an opportunity for American Eagle to gain market share, but also may increase promotional cadence in Aerie's space.
DF Dean Foods
$7.17

-0.21 (-2.85%)

08/17/18
JPMS
08/17/18
DOWNGRADE
JPMS
Underweight
Dean Foods downgraded to Underweight from Neutral at JPMorgan
08/17/18
08/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) downgraded to Underweight from Neutral at JPMorgan with analyst Ken Goldman citing a "number of concerns," including a possible miss for Q3, higher raw milk costs, demand erosion for fluid milk, the risk of further customer attrition, and valuation. 2. Wabtec (WAB) downgraded to Sector Weight from Overweight at KeyBanc with analyst Steve Barger saying he thinks risk/reward has become more balanced in the context of macro and forecasting risk, GE Transport (GE) integration risk and forward valuation. 3. Yum China (YUMC) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Bittner saying needed improving same-store sales could take several quarters as KFC headwinds do not appear transitory. 4. DSW (DSW) downgraded to Negative ahead of expected guidance cut at Susquehanna with analyst Sam Poser saying he expects margins to be challenged due to increased variable costs and gross margin pressure related to the new loyalty program. 5. Sun Communities (SUI) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/17/18
JPMS
08/17/18
DOWNGRADE
Target $6
JPMS
Underweight
Dean Foods downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Ken Goldman downgraded Dean Foods to Underweight from Neutral and cut his price target for shares to $6 from $9, reflecting a "number of concerns," including a possible miss for Q3, higher raw milk costs, demand erosion for fluid milk, the risk of further customer attrition, and valuation. After recently restructuring his working Dean Foods model, Goldman says that "The more we scrubbed the numbers, the less confidence we had that Dean would hit Street forecasts for EPS in any of the next three years."
08/08/18
08/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dean Foods (DF) upgraded to Hold from Sell at Deutsche Bank. 2. Plantronics (PLT) upgraded to Buy from Neutral at Sidoti with the firm citing attractive valuation. 3. CarGurus (CARG) upgraded to Outperform from Market Perform at JMP Securities and to Outperform from Sector Perform at RBC Capital. 4. Bristol-Myers (BMY) upgraded to Neutral from Underweight at Atlantic Equities. 5. Floor & Decor (FND) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying the company continues to post the "best relative performance in the flooring retailing industry." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TXT Textron
$65.09

-2.295 (-3.41%)

04/19/18
WELS
04/19/18
NO CHANGE
Target $72
WELS
Outperform
Textron price target raised to $72 from $67 at Wells Fargo
Wells Fargo analyst Sam Pearlstein raised his price target for Textron to $72 from $67 following quarterly results. The analyst reiterates an Outperform rating on the shares.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
07/19/18
SBSH
07/19/18
NO CHANGE
Target $76
SBSH
Buy
Textron price target raised to $76 from $67 at Citi
Citi analyst Jonathan Raviv raised his price target for Textron to $76 citing an "improving earnings growth picture" following yesterday's Q2 results. Aviation's incremental margin outlook is "broadly positive" and Bell Commercial is stabilizing, Raviv tells investors in a post-earnings research note. He remains a buyer of Textron shares and keeps a Buy rating on the name.
09/26/18
JEFF
09/26/18
NO CHANGE
Target $82
JEFF
Buy
Textron price target raised to $82 from $77 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for Textron to $82 after meeting with CEO Scott Donnelly and CFO Frank Connor. The analyst is "incrementally more positive" on demand in the business jet and commercial helicopter portfolios as well as on the company's product positioning. She keeps a Buy rating on Textron shares.
SNBR Sleep Number
$31.60

-1.33 (-4.04%)

04/20/18
RHCO
04/20/18
NO CHANGE
Target $32
RHCO
Hold
Sleep Number price target lowered to $32 from $35 at SunTrust
SunTrust analyst Keith Hughes lowered his price target on Sleep Number to $32 after the company posted a "weak" Q1, which he says increases expectation pressures for the second half of the year given that the management maintained its FY18 outlook. Hughes says the path to meeting that guidance is "difficult" despite the management's expectations of a turnaround, anticipating "heavy" buyback activity financed in part by debt being added to the balance sheet for the first time. The analyst keeps his Hold rating on Sleep Number.
07/10/18
WEDB
07/10/18
NO CHANGE
Target $65
WEDB
Outperform
Mattress sales 'soft,' Tempur Sealy likely below consensus for Q2, says Wedbush
Following checks with retailers across the U.S., Wedbush analyst Seth Basham told investors in a research note that nationwide brick-and-mortar retail mattress sales declined in the low-single digits in the second quarter, and though sales grew early in the quarter, they declined in May and June. Based on his checks, Basham says 4th of July period sales declined low-single digits to mid-single digits for B&M retailers, driven by steepening traffic declines and ASP gains, and that Tempur Sealy (TPX) specifically is likely to be below consensus for the quarter, with sales trends weakening due to elevated cannibalization rates as customers traded down to new, lower-priced products. He believes Tempur Sealy will maintain at least the low end of of its 2018 EBITDA guidance of $450M-$500M. Additionally, Basham says Sleep Number (SNBR) may be "slightly light" of consensus for the quarter, as his checks show that sales trends remained muted for the 4th of July period. The analyst has an Outperform rating and $65 price target on Tempur Sealy and a Neutral rating and $34 price target on Sleep Number.
07/26/18
PIPR
07/26/18
DOWNGRADE
Target $33
PIPR
Neutral
Sleep Number downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Sleep Number to Neutral and lowered his price target for the shares to $33 from $41. The Q2 earnings report was "inline with consensus but relatively disappointing," Keith tells investors in a research note. Despite a product line refresh, sales trends remain "surprisingly sluggish," the analyst contends. He believes this could be the result of escalating competition from low-price import mattresses and that his dynamic is "unlikely to change in any notable fashion."
09/19/18
WEDB
09/19/18
NO CHANGE
Target $65
WEDB
Outperform
Antidumping petition could lead to relief for mattress cos, says Wedbush
A consortium of U.S. mattress manufacturers yesterday filed an antidumping duty petition with the U.S. Department of Commerce and the U.S. ITC against foam and innerspring mattresses imported from China. In a research note to investors, Wedbush analyst Seth Basham says antidumping duties over 200% could "tip the scales" back in favor of U.S. producers of low-end U.S. mattresses like Tempur Sealy's (TPX) Sealy, but says the impact for Sleep Number (SNBR) is "more limited" with no exposure to the low-mattress segment, and that Purple (PRPL) could benefit "modestly." The analyst believes that more important for Tempur Sealy is the fate of Mattress Firm (MFRM), the largest U.S. mattress retailer, which he continues to expect to file near-term for bankruptcy.

TODAY'S FREE FLY STORIES

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

SBLK

Star Bulk Carriers

$8.21

0.13 (1.61%)

17:03
02/15/19
02/15
17:03
02/15/19
17:03
Hot Stocks
Star Bulk Carriers acquires 95,605 of its common shares »

Star Bulk Carriers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$20.56

0.26 (1.28%)

17:02
02/15/19
02/15
17:02
02/15/19
17:02
Earnings
Hollysys reports Q2 adjusted EPS 73c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AKS

AK Steel

$2.98

-0.015 (-0.50%)

16:58
02/15/19
02/15
16:58
02/15/19
16:58
Syndicate
Breaking Syndicate news story on AK Steel »

AK Steel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
02/15/19
02/15
16:55
02/15/19
16:55
General news
Treasury Market Summary: i »

Treasury Market Summary:…

LPTX

Leap Therapeutics

$1.65

(0.00%)

16:53
02/15/19
02/15
16:53
02/15/19
16:53
Hot Stocks
Valence Helix Investments discloses 10.99% stake in Leap Therapeutics »

Valence Helix disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$23.25

-0.24 (-1.02%)

16:52
02/15/19
02/15
16:52
02/15/19
16:52
Hot Stocks
Mid Penn Bancorp seeks approval to relocate Allentown Boulevard branch »

Mid Penn Bank, subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$423.79

8.54 (2.06%)

, AMGN

Amgen

$188.31

1.6 (0.86%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
Regeneron says EPO revokes Immunex's European patent No. 2,990,420 »

Regeneron…

REGN

Regeneron

$423.79

8.54 (2.06%)

AMGN

Amgen

$188.31

1.6 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 28

    Apr

  • 13

    May

UPS

UPS

$110.89

-0.91 (-0.81%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
UPS CFO sells 9.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DAL

Delta Air Lines

$51.09

0.58 (1.15%)

16:43
02/15/19
02/15
16:43
02/15/19
16:43
Syndicate
Breaking Syndicate news story on Delta Air Lines »

Delta Air Lines files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$110.89

-0.91 (-0.81%)

16:42
02/15/19
02/15
16:42
02/15/19
16:42
Hot Stocks
UPS raises quarterly dividend to 96c per share from 91c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.